Tiedemann Advisors’s DexCom DXCM Stock Holding History

Tiedemann Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,912	Closed	-$1.38M	–	316
2021 Q2	$1.38M	Buy	+12,912	New	+$1.24M	0.06%	140

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tiedemann Advisors's DXCM Position: Q3 2021 in Review

Tiedemann Advisors sold out of DexCom (DXCM) in Q3 2021, closing a stake of 12,912 shares — an estimated $1.38M sold.

Tiedemann Advisors first reported a position in DXCM in Q2 2021 and held it in 1 quarter. The position peaked at $1.38M in Q2 2021. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2021.

Tiedemann Advisors reported no remaining DexCom position as of Q3 2021 after selling out during the quarter.
Tiedemann Advisors sold 12,912 DexCom shares in Q3 2021, an estimated $1.38M.
Tiedemann Advisors first reported a position in DexCom in Q2 2021 and held it in 1 quarter.
Tiedemann Advisors's DexCom position peaked at $1.38M in Q2 2021.
795 funds tracked by Wall St. Rank held DexCom as of Q3 2021.

Based on Tiedemann Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.